Wallace & Graham

Winning justice on behalf of hardworking people is what Wallace & Graham’s attorneys are all about.

FDA

CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR) — FDA issues a safety warning related to diabetes medicine and amputations

Updated June 19, 2017 In the News: Drug Safety                                                         FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR)  On March 16, 2017, the Food and Drug Administration…

FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR)

In the News: Drug Safety May 18, 2017 FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR) On March 16, 2017, the Food and Drug Administration (FDA) issued a Drug Safety Announcement related to the diabetes medicine CANAGLIFLOZIN based on data from two large clinical trials. CANAGLIFLOZIN is used to treat individuals with type 2…